VERTEX PHARMACEUTICALS INC / MA

SEC 4 · Filed

0000875320-26-000106Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 25, 2026

Sale by Atkinson Edward Morrow III

Security
Common Stock
Code
S
Shares
668
Price per share
486.35
Structured facts
{
  "code": "S",
  "date": "2026-02-25",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Mr. Atkinson\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025."
  },
  "owners": [
    {
      "cik": "0001914164",
      "name": "Atkinson Edward Morrow III",
      "roles": [
        "officer"
      ],
      "title": "EVP, Chief Technical Ops. Off."
    }
  ],
  "ownership": "D",
  "post_shares": "18432",
  "price": "486.35",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "668",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 24, 2026

Payment of exercise price or tax by delivery of securities by Atkinson Edward Morrow III

Security
Common Stock
Code
F
Shares
1,627
Price per share
485.11
Structured facts
{
  "code": "F",
  "date": "2026-02-24",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {},
  "owners": [
    {
      "cik": "0001914164",
      "name": "Atkinson Edward Morrow III",
      "roles": [
        "officer"
      ],
      "title": "EVP, Chief Technical Ops. Off."
    }
  ],
  "ownership": "D",
  "post_shares": "19100",
  "price": "485.11",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1627",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}